{"id":"W2889898143","doi":"10.1016/j.ejca.2018.08.002","title":"Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital","funders":"Institut Gustave-Roussy; AstraZeneca; Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Fulvestrant; Medicine; Internal medicine; Placebo; Oncology; Population; Cancer; Breast cancer; Adverse effect; Estrogen receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006391951,0.0007683698,0.001241171,0.0003305275,0.0001670578,0.0005574076,0.000461629,0.0006948562,0.004952818],"category_scores_gemma":[0.0005163001,0.0002229784,0.001565236,0.0002633638,0.0004162913,0.0007464137,0.000295122,0.001383668,0.0005281551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004588082,"about_ca_system_score_gemma":0.0005035237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007108854,"about_ca_topic_score_gemma":0.002646062,"domain_scores_codex":[0.999779,0.0000797783,0.00001495721,0.00003379092,0.00002002187,0.00007244464],"domain_scores_gemma":[0.9997869,0.00004718489,0.00005118971,0.00001790865,0.00001039478,0.00008639644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8908789,0.008698864,0.001805512,0.0006720428,0.001663988,0.00005657388,0.00005087414,0.001036642,0.01267197,0.0002293982,0.001807594,0.08042765],"study_design_scores_gemma":[0.5261859,0.425693,0.03279012,0.0001469904,0.003773312,0.000266679,0.0001370647,0.001661537,0.004570786,0.0004899713,0.004218874,0.00006580516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988969,0.006804646,0.0001705158,0.000602119,0.0002134602,0.0002211058,0.0008580825,0.00005410044,0.002106914],"genre_scores_gemma":[0.9884771,0.004371494,0.0004469889,0.0007592519,0.0002251372,0.0003414551,0.001409778,0.00001276515,0.003956031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004952818,"threshold_uncertainty_score":0.01656884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02433777903888868,"score_gpt":0.2946554894638917,"score_spread":0.270317710425003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}